Search PubMed⌕ Search

Biomedical subjects

E Kim

Publications and source records attributed to E Kim.

312 records · Page 18Linked to original sources
PubMedDate not supplied

Modified technique for fine needle aspiration biopsy that eliminates needle manipulation.

OBJECTIVE: To evaluate a modified technique of fine needle aspiration biopsy that eliminates needle manipulation after aspiration. STUDY DESIGN: Fine needle aspiration biopsy of 112 palpable lesions was performed using both the conventional and modified techniques. Cellularity, cell preservation and diagnostic yield of the new procedure were compared to those of the conventional technique. RESULTS: Cytologic smears prepared from each method were comparable in quality, quantity and diagnostic yield. CONCLUSION: The modified approach eliminates the hazard of needle manipulation without diminishing the diagnostic efficacy of fine needle aspiration biopsy.

Biopsy, Needle↗
PubMedDate not supplied

Enhancement of gene transfer efficiency into human cancer cells by modification of retroviral vectors and addition of chemicals.

Retroviral vectors have recently experienced limited use in cancer gene therapy mainly due to poor transduction efficiency. To overcome this drawback, we attempted to enhance the transduction efficiency by employing different retroviral packaging cell lines and chemical additives. The retrovirus from the PG13 packaging cell line gave mostly higher or similar transduction efficiencies in a variety of human cancer cell lines compared to the retrovirus from the PA317, Bing, or FLYRD18 packaging cell line. A cationic liposome, especially Lipofectamine, significantly enhanced the transduction efficiency of a retrovirus. However, the retrovirus derived from the PG13 cell line could not infect the murine cell line efficiently even after Lipofectamine treatment. Furthermore, chloroquine did not improve the transduction efficiency regardless of the presence of chemical additives. These results, therefore, suggested that the transduction efficiency of a retrovirus in human cancer cells can certainly be improved when a proper packaging cell line is chosen. In addition, this study implied that Lipofectamine is a superb additive to enhance the transduction efficiency of a retrovirus via a specific virus envelope protein-receptor interaction for virus entry, and that receptor-mediated endocytosis does not seem to be the leading route of virus delivery to liberate a virus genome.

3T3 Cells↗
PubMedDate not supplied

Development of a PHC nursing information system in Korea.

WHO has established collaborating centres at educational institutions throughout the world to assist with WHO research. In 1988 a WHO Collaborating Centre was inaugurated at Yonsei University College of Nursing in Korea. Since then two important research projects have been completed for establishing a data bank of human resources of nursing for primary health care (PHC) in Korea. Both projects strengthen the PHC nursing information systems in Korea and, as such, are beginning to develop PHC networks throughout Korea, passing on information to an international network system. Below, the rationale behind the two projects, the methodology and the results.

Computer Communication Networks↗
PubMedDate not supplied

Perinatal toxicology screening: comparison of various maternal and neonatal samples.

OBJECTIVES: Because cocaine metabolites are concentrated in amniotic fluid, we designed this study to assess the usefulness of amniotic fluid and that of neonatal gastric aspirate for perinatal drug screening and to compare the concentration of cocaine metabolites in various maternal and neonatal specimens. STUDY DESIGN: We compared the reliability of various maternal and neonatal specimens for detecting drug exposure and the concentration of cocaine metabolites in these specimens. RESULTS: Our data showed that screening for perinatal drug abuse with any single specimen leads to false-negative results. Drug screening with neonatal amniotic fluid, gastric aspirate, or cord blood did not improve the reliability of perinatal drug screening. CONCLUSION: Testing more than one type of body fluid may increase the reliability of perinatal drug screening.

Amniotic Fluid↗
PubMedDate not supplied

Using genetically engineered mice to understand apolipoprotein-B deficiency syndromes in humans.

Several human diseases are characterized by defects in the synthesis and secretion of the apolipoprotein (apo) B-containing lipoproteins. Familial hypobetalipoproteinemia is caused by mutations in the apo-B gene and is characterized by abnormally low plasma concentrations of apo-B and low-density lipoprotein (LDL) cholesterol. Another apo-B deficiency syndrome, abetalipoproteinemia, is caused by mutations in the gene for microsomal triglyceride transfer protein (MTP). MTP is a microsomal protein that is thought to transfer lipids to the apo-B protein as it is translated, allowing it to attain the proper conformation for lipoprotein assembly. A third apo-B deficiency syndrome, Anderson's disease (or chylomicron retention disease), is characterized by the inability to secrete apo-B-containing chylomicrons from the intestine but an apparently normal capacity to secrete lipoproteins from the liver. To more fully understand these human apo-B deficiency syndromes, our laboratory has generated and characterized gene-targeted mouse models. This review summarizes what has been learned from these animal models.

Abetalipoproteinemia↗